immunity News and Research

RSS

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

The University of Ottawa has earned a total of 10 Canada Research Chairs (CRCs) covering a broad scope of subjects, from the exploration of disruptive impacts of stress on higher brain functions to the need to preserve Indigenous traditional cultural memories, and emerging computing technologies that pave the way to smart cities.

18 Dec 2020

Continued vigilance is required in England following exit from second lockdown

Researchers in the UK have presented data from the latest in a series of community surveys assessing the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England.

17 Dec 2020

SARS-CoV-2 surface proteins alter the expression of key chemokines and cytokines in cell lines

Researchers from the Washington University School of Medicine, United States of America, recently demonstrated that the SARS-CoV-2 surface proteins alone triggered innate cell activity and the interferon signaling pathway.

17 Dec 2020

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread

Since the COVID 19 pandemic, it has been established that the causative virus, SARS-CoV-2 gains entry to the target host cell via its spike glycoprotein.

17 Dec 2020

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Researchers from the University of Rochester, USA, has produced an AI-based study that analyzes the social media platform Twitter to gauge public opinions in the US surrounding SARS-CoV-2 vaccines to shed greater light on this issue.

15 Dec 2020

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

A team of US-based researchers recently conducted an illuminating study that explores this method and its potential uses. In doing so, they have underscored the potential utility of wastewater surveillance in managing SARS-CoV-2 outbreaks.

15 Dec 2020

Tumor's stiff-arm tactic limits the effectiveness of immunotherapeutics

In a paper just published in the Journal for the Immunotherapy of Cancer (doi:10.1136/jitc-2020-001712), Dr Herbert, Head of Discovery at InsideOutBio, asks whether cancer cells stiff-arm immune cells just like rugby players push off defenders from the other team.

15 Dec 2020

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

During a Dec. 8 press conference about Operation Warp Speed, President Donald Trump likened the spread of the coronavirus throughout the population — which experts agree bestows some immunity on the people who became ill — to having a COVID-19 vaccine.

15 Dec 2020

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020

Pandemic backlash jeopardizes public health powers, leaders

A series examining how the U.S. public health front lines have been left understaffed and ill-prepared to save us from the coronavirus pandemic.

15 Dec 2020

DFG establishes “COVID-19 Focus Funding” to address questions on coronavirus pandemic

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has made its first decisions in the new COVID-19 Focus Funding instrument. These decisions will enable 33 projects to immediately begin research on immunity, host susceptibility and pathomechanisms of infection with SARS-CoV-2.

15 Dec 2020

Study examines psychological, social predictors of U.S. adults' willingness to get COVID-19 vaccine

The first COVID-19 vaccine has received emergency use authorization. Yet a key question remains: Will U.S. adults be willing to get it?

14 Dec 2020

New method shortens the timeline to generate mice for vaccine research

To develop vaccines and investigate human immune responses, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors, which are specialized antibodies bound to the B cell membrane.

14 Dec 2020

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

The onslaught of the COVID-19 pandemic, the hunt for a drug, and the successful development of a vaccine has impacted people beyond measure worldwide.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

immunity News and Research

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

Continued vigilance is required in England following exit from second lockdown

SARS-CoV-2 surface proteins alter the expression of key chemokines and cytokines in cell lines

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

Tumor's stiff-arm tactic limits the effectiveness of immunotherapeutics

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

Reliable Antibodies Testing for SARS-CoV-2

Pandemic backlash jeopardizes public health powers, leaders

DFG establishes “COVID-19 Focus Funding” to address questions on coronavirus pandemic

Study examines psychological, social predictors of U.S. adults' willingness to get COVID-19 vaccine

New method shortens the timeline to generate mice for vaccine research

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Risk factors for COVID-19 vaccine acceptance

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News